Capital Fund Management (CFM)
CRL icon

Capital Fund Management (CFM)’s Charles River Laboratories CRL Stock Holding History

Capital Fund Management (CFM)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,786
Closed -$5.13M – 2049
2024
Q4 		$5.13M Buy
27,786
+3,371
+14% +$649K 0.01% 1067
2024
Q3 		$4.81M Buy
24,415
+4,459
+22% +$927K 0.01% 1036
2024
Q2 		$4.12M Buy
+19,956
New +$4.52M 0.01% 1044
2020
Q1 		– Sell
-9,600
Closed -$1.47M – 1621
2019
Q4 		$1.47M Buy
+9,600
New +$1.33M 0.01% 952
2019
Q3 		– Sell
-21,582
Closed -$3.06M – 1696
2019
Q2 		$3.06M Buy
+21,582
New +$2.93M 0.03% 676
2019
Q1 		– Sell
-5,600
Closed -$634K – 1724
2018
Q4 		$634K Buy
+5,600
New +$701K 0.01% 1271
2018
Q3 		– Sell
-1,800
Closed -$202K – 2010
2018
Q2 		$202K Sell
1,800
-9,300
-84% -$1.01M ﹤0.01% 1914
2018
Q1 		$1.19M Buy
+11,100
New +$1.2M 0.01% 1183
2016
Q3 		– Sell
-10,192
Closed -$840K – 1587
2016
Q2 		$840K Buy
+10,192
New +$839K 0.01% 1011
2014
Q3 		– Sell
-17,900
Closed -$958K – 1552
2014
Q2 		$958K Buy
+17,900
New +$982K 0.01% 982
2013
Q3 		– Sell
-66,517
Closed -$2.73M – 1621
2013
Q2 		$2.73M Buy
+66,517
New +$2.85M 0.04% 528

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital Fund Management (CFM)'s CRL Position: Q1 2025 in Review

Capital Fund Management (CFM) sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 27,786 shares — an estimated $5.13M sold.

Capital Fund Management (CFM) first reported a position in CRL in Q2 2013 and held it in 11 quarters. The position peaked at $5.13M in Q4 2024. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Capital Fund Management (CFM) reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 27,786 Charles River Laboratories shares in Q1 2025, an estimated $5.13M.
  • Capital Fund Management (CFM) first reported a position in Charles River Laboratories in Q2 2013 and held it in 11 quarters.
  • Capital Fund Management (CFM)'s Charles River Laboratories position peaked at $5.13M in Q4 2024.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2025, filed 14 May 2025.